Clinical Relevance of Acute Mixed-Lineage Leukemias

References

• Greaves M.F., Chan L.C., Furley A.J.W., Watt S.M., Molgaard H.V. Lineage promiscuity in hemopoietic differentiation and leukemia. Blood 1986; 67: 1–11
   PubMed Web of Science ®Google Scholar
• Paietta E. Ambiguous phenotypes in acute leukemia. Leuk. Lymph. 1990; 2: 17–33
   PubMedGoogle Scholar
• Coco LoF. Hybrid phenotypes and lineage promiscuity in acute leukemia. Haematologica 1991; 76: 215–225
   PubMedGoogle Scholar
• Maytreyan V., Gale R.P. What is hybrid leukemia. Leuk. Res. 1989; 13: 725–728
   PubMed Web of Science ®Google Scholar
• Hoffbrand A.V., Leber V.F., Browett P.J., Norton J.D. Mixed acute leukemias. Blood Rev. 1988; 2: 9–15
   PubMed Web of Science ®Google Scholar
• Gale R.P., Ben-Bassat I. Hybrid acute leukemia. Br. J. Haematol. 1987; 65: 261–264
   PubMed Web of Science ®Google Scholar
• Stass S.A., Mirro J. Lineage heterogeneity in acute leukemia: Acute mixed lineage-leukemia and lineage switch. Clinics Hematol. 1986; 15: 811–827
   PubMedGoogle Scholar
• Chan L.C., Pegram S.M., Greaves M.F. Contribution of immunophenotype to the classification and differential diagnosis. Lancet 1985; i: 475–479
   Google Scholar
• Foon K.A., Todd R.F. III. Immunologic classification of leukemia and lymphoma. Blood 1986; 68: 1–31
   PubMed Web of Science ®Google Scholar
• Freedman A.S., Nadler L.M. Cell surface markers in hematologic malignancies. Sem. Oncol. 1987; 14: 193–212
   PubMed Web of Science ®Google Scholar
• Drexler H.G., Gignac S.M., Minowada J. Routine immunophenotype in acute leukemias. Blut 1988; 57: 327–339
   PubMedGoogle Scholar
• Janossy G., Coustan-Smith E., Campana D. The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukemia: A study of 500 cases. Leukemia 1989; 3: 170–181
   PubMed Web of Science ®Google Scholar
• Del Vecchio L., Schiavone, Ferrara F., Pace E., Lo Pardo C., Pacetti M., Russo M., Cirillo D., Vacca C. Immunodiagnosis of acute leukemia displaying ectopic antigens: Proposal for a classification of promiscuous phenotypes. Am. J. Hematol. 1989; 31: 173–180
   PubMed Web of Science ®Google Scholar
• Catovsky D., Matutes E., Buccheri V., Shetty V., Hanslip J., Morilla R. A classification of acute leukemia for the 1990s. Ann. Hematol. 1991; 62: 16–21
   PubMed Web of Science ®Google Scholar
• Vaickus L., Foon K.A. Immunobiology of acute leukemia. Neoplastic Disease of the Blood, P.H. Wiernik, G.P. Canellos, R.A. Kyle, C.A. Schiffer. Churchill Livingstone, New York 1991; 183–215
   Google Scholar
• Bain B.J. Leukemia diagnosis—A Guide to the FAB Classification. Gower Medical Publishing, London, 61–88
   Google Scholar
• Uckun F.M. Regulation of human B-cell ontogeny. Blood 1990; 76: 1908–1923
   PubMed Web of Science ®Google Scholar
• Loken M.R., Shah V.O., Dattilio K.L., Civin C.I. Flow cytometric analysis of human bone marrow: II. Normal B lymphocyte development. Blood 1987; 70: 1316–1324
   PubMed Web of Science ®Google Scholar
• Haynes B.F., Denning S.M., Singer K.H., Kurtz-Berg J. Ontogeny of T-cell precursors: A model for the initial stages of human T-cell development. Immunol. Today 1989; 10: 87–91
   PubMedGoogle Scholar
• Terstappen L. W. M. M., Wang S., Picker L.J. Flow cytometric assessment of human T-cell differentiation in thymus and bone marrow. Blood 1992; 79: 666–677
   PubMed Web of Science ®Google Scholar
• Vodilenich L., Tax W., Bai Y.K., Pegram S.L., Capel P., Greaves M.F. A monoclonal antibody (WT1) for detecting leukaemias of T-cell precursors (T-ALL). Blood 1983; 62: 1108–1113
   PubMed Web of Science ®Google Scholar
• Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D.A.G., Gralnick H.R., Sultan C. Proposed revised criteria for the classification of acute myeloid leukemia. Ann. Intern. Med. 1985; 103: 626–629
   PubMed Web of Science ®Google Scholar
• Knapp W., Dorken B., Rieber P., Schmidt R.E., Stein H., Von dem Borne A. E. G. K. CD antigens 1989. Blood 1989; 74: 1448–1450
   PubMed Web of Science ®Google Scholar
• Meuer S.C., Hussey R.E., Fabbi M., Fox D., Acuto O., Fitzgerald K.A., Hodgdon J.C., Protentis J.P., Schlossman S.F., Reinherz E.L. An alternative pathway of T-cell activation: A functional role for the kd T11 sheep erythrocyte receptor protein. Cell 1985; 36: 897–904
   Web of Science ®Google Scholar
• Claxton D.F., Reeding C.L., Najarajan L. Correlation of CD2 expression with PML gene breakpoints in patients with acute promyelocytic leukemia. Blood 1992; 80: 582–586
   PubMed Web of Science ®Google Scholar
• Van De Velde V., Von Hoegen I., Luo W., Parnes J.R., Thelemans K. The B-cell surface protein CD72/Lyb-2 is the ligand for CD5. Nature 1991; 351: 662–663
   PubMed Web of Science ®Google Scholar
• Aruffo A., Melnick M.B., Linsley P.S., Seed B. The lymphocyte glycoprotein CD6 contains a repeated domain structure characteristic of a new family of cell surface and secreted proteins. J. Exper. Med. 1991; 174: 949–952
   PubMed Web of Science ®Google Scholar
• LeBien T.W., McCormack R.T. The common acute lymphoblastic leukemia antigen (CD 10)—Emancipation from a functional enigma. Blood 1989; 73: 625–635
   PubMed Web of Science ®Google Scholar
• Griesinger F., Greenberg J.M., Kersey J.K. T-cell receptor gamma and delta rearrangements in hematologic malignancies. Relationship to lymphoid differentiation. J. Clin. Invest. 1989; 84: 506–510
   PubMed Web of Science ®Google Scholar
• Philip P.J.M., Monpoux F., Sudaka I., Baudoin F., Bayle J., Bene M.C., Faure G.C., the GEIL. Multiphenotypic acute leukemias: Clinicopathologic correlations and response to therapy. Leuk. Lymph. 1992; 7: 489–495
   PubMed Web of Science ®Google Scholar
• Grumayer E.R., Griesinger F., Hummel D.S., Brunning R.D., Kersey J.H. Identification of novel B-lineage cells in human fetal bone marrow that coexpress CD7. Blood 1991; 77: 64–68
   PubMed Web of Science ®Google Scholar
• Drexler H.G., Thiel E., Ludwig W.D. Review of the incidence and clinical relevance of myeloid antigen-positive acute lymphoblastic leukemia. Leukemia 1991; 8: 637–645
   Google Scholar
• Drexler H.G. Myeloid antigen expression in adult lymphoblastic leukemia. N. Engl. J. Med. 1987; 316: 1156
   PubMed Web of Science ®Google Scholar
• Martini E., D'Hautcourt J.L., Brando B., Lawry J., O'Connor J.E., Sansonetty F. First European Quality Control of Cellular Phenotyping by Flow Cytometry. Editions Frison-Roche, Paris 1990; 62–64
   Google Scholar
• Ferrara F., De Rosa C., Fasanaro A., Mele G., Finizio O., Schiavone E.M., Spada O.A., Rametta V., Vecchio DelL. Myeloid antigen expression in adult acute lymphoblastic leukemia: clinico-hematological correlations and prognostic relevance. Hematol. Pathol. 1990; 4: 93–98
   PubMedGoogle Scholar
• Fialkow P.J., Singer J.W., Adamson J.V., Vaidya K., Dow L.W., Ocs J., Moohr J.V. Acute nonlymphocytic leukemia: Heterogeneity of stem cell origin. Blood 1981; 57: 1068–1073
   PubMed Web of Science ®Google Scholar
• Ferraris A.M., Raskind W.K., Bjornson B.H., Jacobson R.J., Singer J.W., Fialkow P.J. Heterogeneity of B-cell involvement in acute nonlymphocytic leukemia. Blood 1985; 66: 342–351
   PubMed Web of Science ®Google Scholar
• Tricot G., Mecucci C., Van de Berghe H. Evolution of the myelodysplastic syndromes. Br. J. Haematol. 1986; 63: 609–614
   PubMed Web of Science ®Google Scholar
• Sobol R.E., Mick R., Royston I. Clinical importance of myeloid antigen expression in adult acute lymphoblastic leukemia. N. Engl. J. Med. 1987; 316: 1111–1117
   PubMed Web of Science ®Google Scholar
• Urbano-Ispizua A., Matutes E., Villamor N. Clinical significance of the presence of myeloid associated antigens in acute lymphoblastic leukemia. Br. J. Haematol. 1990; 75: 202–207
   PubMed Web of Science ®Google Scholar
• Childs C.C., Hirsch-Ginsberg C., Walters R.S. Myeloid surface antigens positive acute lymphoblastic leukemia (My + ALL): Immunophenotypic, ultrastructural, cytogenetic and molecular characteristics. Leukemia 1989; 3: 777–783
   PubMed Web of Science ®Google Scholar
• Guyotat D., Campos L., Shi Z.H. Myeloid surface antigen expression in adult acute lymphoblastic leukemia. Leukemia 1990; 4: 664–666
   PubMed Web of Science ®Google Scholar
• Pui C.H., Behm F.G., Singh B. Myeloid-associated antigen expression lacks prognostic value in childhood acute lymphoblastic leukemia treated with intensive multiagent chemotherapy. Blood 1989; 75: 198–202
   Web of Science ®Google Scholar
• Wiersma S.R., Ortega J., Sobel E., Weinberg K.I. Clinical importance of myeloid-antigens expression in acute lymphoblastic leukemia of childhood. N. Engl. J. Med. 1991; 324: 800–808
   PubMed Web of Science ®Google Scholar
• Kurtzberg J., Waldmann T.A., Davey M.P. CD7+, CD4-, CD8- acute leukemia: A syndrome of malignant pluripotent hematopoietic cell. Blood 1989; 73: 381–390
   PubMed Web of Science ®Google Scholar
• Ferrara F., Cimino R., Antinolfi I. Clinical relevance of immunological dissection in T-ALL: A report on 20 cases with stem cell (CD7+, CD4-, CD8-, CD1-) phenotype. Am. J. Hematol. 1992; 40: 98–102
   PubMed Web of Science ®Google Scholar
• Kurtzberg J., Denning S.L., Nycum L.M., Singer K.H., Haynes B.F. Immature human thymocytes can be driven to differentiate into nonlymphoid lineages by cytokines from the thymic epithelial cells. Proc. Nat. Acad. Sci. USA 1989; 86: 7575–7579
   PubMed Web of Science ®Google Scholar
• Griesinger F., Arthur D.C., Brunning R. Mature T-lineage leukemia with growth factor-induced multilineage differentiation. J. Exp. Med. 1989; 169: 1101–1120
   PubMed Web of Science ®Google Scholar
• Thiel E., Krantz B.R., Raghavachar A. Prethymic phenotype and genotype of pre-T (CD7 + /ER-) cell leukemia and its clinical significance within adult acute lymphoblastic leukemia. Blood 1989; 73: 1247–1258
   PubMed Web of Science ®Google Scholar
• Crist W.M., Shuster J.J., Falletta J. Clinical features and outcome in childhood T-cell leukemia-lymphoma according to stage of thymocyte differentiation: a Pediatric Oncology Group Study. Blood 1988; 72: 1891–1897
   PubMed Web of Science ®Google Scholar
• Del Vecchio L., Finizio O., Lo Pardo C. Coordinate expression of T-cell antigens on acute myelogenous leukemia and of myeloid antigens on T-acute lymphoblastic leukemia. Speculation on a highly balanced bilinearity. Leukemia 1991; 5: 815–818
   PubMed Web of Science ®Google Scholar
• Lo Coco F., De Rossi G., Pasqualetti D. CD7 positive acute myeloid leukemia: A subtype associated with cell immaturity. Br. J. Haematol 1989; 73: 480–485
   PubMed Web of Science ®Google Scholar
• Auger M.J., Ross J.A., Ross F.M. CD7 positive acute myeloblasts leukaemia: an heterogeneous leukaemic subtype. Leuk. Lymph. 1992; 6: 487–491
   Web of Science ®Google Scholar
• Jensen A.W., Hokland M., Jorgensen H. Solitary expression of CD7 among T-cell antigens in acute myeloid leukemia: Identification of a group of patients with similar T-cell receptor β and delta rearrangements and course of disease suggestive of poor prognosis. Blood 1991; 78: 1292–1300
   PubMed Web of Science ®Google Scholar
• Norton J.D., Campana D., Hoffbrand A.V. Rearrangement of immunoglobulin and T-cell antigen receptor genes in acute myeloid leukemia with lymphoid-associated markers. Leukemia 1987; 1: 757–761
   PubMed Web of Science ®Google Scholar
• Zutter M.M., Martin P.J., Hanke D., Kidd P.G. CD7+ acute non-lymphocytic leukemia: evidence for an early multipotential progenitor. Leuk. Res. 1990; 14: 23–26
   PubMed Web of Science ®Google Scholar
• Ferrara F., Finizio O., De Rosa C. Acute myeloid leukemia expressing T-cell antigens: Clinico-hematological report on 6 cases. Leuk. Lymph. 1990; 3: 217–222
   PubMed Web of Science ®Google Scholar
• Cross A.H., Goorha R.M., Nuss R. Acute myeloid leukemia with T-lymphoid features: A distinct biologic and clinical entity. Blood 1988; 72: 579–587
   PubMed Web of Science ®Google Scholar
• Pui C.H., Raimondi S.C., Head D.R. Characterization of childhood acute leukemia with multiple myeloid and lymphoid markers at diagnosis and at relapse. Blood 1991; 78: 1327–1337
   PubMed Web of Science ®Google Scholar
• Campos L., Guyotat D., Gentilhomme O. Expression of a B-lymphoid differentiation antigen (CD 19) on acute nonlymphoblastic leukemia cells. Eur. J. Haematol. 1987; 38: 220–224
   PubMed Web of Science ®Google Scholar
• Oster W., Konig K., Ludwig W.D. Incidence of lineage promiscuity in acute myeloblastic leukemia: Diagnostic implication of immunoglobulin and T-cell receptor gene rearrangement analysis and immunological phenotyping. Leuk. Res. 1988; 12: 887–895
   PubMed Web of Science ®Google Scholar
• Paietta E., Van Ness B., Bennett J. Lymphoid lineage-associated features in acute myeloid leukaemia: Phenotypic and genotypic correlations. Br. J. Haematol. 1992; 82: 324–331
   PubMed Web of Science ®Google Scholar